 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - LIGAND PHARMACEUTICALS INC (LGND)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-03 Purchase | 2019-09-04 7:30 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 750 | $87.01 | $65,258 | 67,203 (Indirect Direct) | View |
| 2019-09-03 Purchase | 2019-09-03 7:34 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 500 | $86.18 | $43,091 | 17,151 (Direct) | View |
| 2019-08-05 Purchase | 2019-08-06 5:18 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 746 | $90.01 | $67,146 | 66,453 (Indirect Direct) | View |
| 2019-08-02 Purchase | 2019-08-05 7:04 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 1,000 | $93.59 | $93,594 | 49,474 (Direct) | View |
| 2019-08-02 Purchase | 2019-08-05 6:56 pm | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 1,000 | $95.98 | $95,980 | 26,359 (Direct) | View |
| 2019-07-31 Sale | 2019-08-01 2:49 pm | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 4,091 | $94.45 | $386,395 | 23,600 (Direct) | View |
| 2019-07-31 Purchase | 2019-07-31 7:26 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,850 | $95.45 | $176,582 | 146,749 (Direct) | View |
| 2019-07-29 Purchase | 2019-07-31 6:50 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 4,004 | $99.22 | $397,287 | 65,707 (Indirect Direct) | View |
| 2019-06-11 Purchase | 2019-06-12 6:51 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 250 | $107 | $26,753 | 61,703 (Indirect Direct) | View |
| 2019-05-31 Purchase | 2019-05-31 7:29 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,000 | $108.2 | $108,202 | 144,899 (Direct) | View |
| 2019-05-29 Purchase | 2019-05-31 6:27 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 1,000 | $109.5 | $109,510 | 60,618 (Indirect Direct) | View |
| 2019-05-20 Purchase | 2019-05-22 5:36 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 250 | $112 | $28,003 | 59,618 (Indirect Direct) | View |
| 2019-05-14 Purchase | 2019-05-16 3:54 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 250 | $112.5 | $28,128 | 59,368 (Indirect Direct) | View |
| 2019-05-14 Purchase | 2019-05-14 7:57 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,500 | $113.5 | $283,750 | 143,899 (Direct) | View |
| 2019-05-14 Sale | 2019-05-14 7:56 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,500 | $112.9 | $282,300 | 28,042 (Direct) | View |
| 2019-03-13 Purchase | 2019-03-15 1:59 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 202 | $112.5 | $22,727 | 59,118 (Direct Indirect) | View |
| 2019-03-13 Purchase | 2019-03-15 1:58 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,500 | $114.3 | $285,725 | 141,399 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-12 Exercise | 2019-11-13 4:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,001 | $21.92 | 144,620 (Direct) | View |
| 2019-11-12 Exercise | 2019-11-13 4:07 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,001 | $21.92 | 144,620 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-16 6:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 1,431 | $0 | 5,283 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-16 6:01 pm | 2020-10-15 2029-10-15 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 5,283 | $107.8 | 5,283 (Direct) | View |
| 2019-09-19 Purchase | 2019-09-24 7:11 pm | N/A 2023-05-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,175,000 | $988,469 | 1,175,000 (Direct) | View |
| 2019-09-19 Purchase | 2019-09-23 10:14 am | N/A 2023-05-15 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 1,175,000 | $989,938 | 1,175,000 (Direct) | View |
| 2019-09-19 Purchase | 2019-09-23 10:14 am | N/A 2023-05-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,000,000 | $841,250 | 1,000,000 (Direct) | View |
| 2019-09-05 Exercise | 2019-09-05 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,005 | $21.92 | 143,619 (Direct) | View |
| 2019-09-05 Exercise | 2019-09-05 7:24 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,005 | $21.92 | 143,619 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-13 1:45 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,163 | $21.92 | 142,614 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-13 1:45 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,163 | $21.92 | 142,614 (Direct) | View |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 669 | $56.26 | 47,172 (Direct) | View |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 424 | $85.79 | 47,172 (Direct) | View |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A 2025-02-10 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 669 | $56.26 | 47,172 (Direct) | View |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 424 | $85.79 | 47,172 (Direct) | View |
| 2019-08-01 Exercise | 2019-08-05 7:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,500 | $32.3 | 24,784 (Direct) | View |
| 2019-08-01 Tax Withholding | 2019-08-05 7:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 847 | $95.58 | 24,784 (Direct) | View |
| 2019-08-01 Exercise | 2019-08-05 7:00 pm | N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,500 | $32.3 | 24,784 (Direct) | View |
| 2019-06-28 Other | 2019-07-02 9:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 182 | $97.03 | 46,079 (Direct) | View |
| 2019-06-28 Other | 2019-07-02 9:49 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 182 | $97.03 | 16,651 (Direct) | View |
| 2019-06-11 Exercise | 2019-06-12 6:50 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,004 | $21.92 | 141,451 (Direct) | View |
| 2019-06-11 Exercise | 2019-06-12 6:50 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,004 | $21.92 | 141,451 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 12:15 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 835 | $0 | 27,691 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 12:15 pm | N/A 2029-06-06 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 4,071 | $113.6 | 27,691 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 835 | $0 | 61,453 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:55 pm | N/A 2029-06-06 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 4,071 | $113.6 | 61,453 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 835 | $0 | 48,474 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:54 pm | N/A 2029-06-06 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 4,071 | $113.6 | 48,474 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:52 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 835 | $0 | 4,071 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:52 pm | N/A 2029-06-06 | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 4,071 | $113.6 | 4,071 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:48 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 835 | $0 | 26,377 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:48 pm | N/A 2029-06-06 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 4,071 | $113.6 | 26,377 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:46 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 835 | $0 | 22,284 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:46 pm | N/A 2029-06-06 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 4,071 | $113.6 | 22,284 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 835 | $0 | 25,359 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 6:44 pm | N/A 2029-06-06 | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 4,071 | $113.6 | 25,359 (Direct) | View |
| 2019-05-14 Exercise | 2019-05-14 7:56 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,500 | $17.88 | 28,042 (Direct) | View |
| 2019-05-14 Exercise | 2019-05-14 7:56 pm | N/A 2019-05-29 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,500 | $17.88 | 28,042 (Direct) | View |
| 2019-03-14 Exercise | 2019-03-15 2:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 14,894 | $9.97 | 140,447 (Direct) | View |
| 2019-03-14 Exercise | 2019-03-15 2:00 pm | N/A 2021-04-18 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 14,894 | $9.97 | 140,447 (Direct) | View |
| 2019-02-11 Option Award | 2019-02-13 4:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 6,404 | $0 | 29,298 (Direct) | View |
| 2019-02-11 Option Award | 2019-02-13 4:35 pm | N/A 2029-03-02 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 29,298 | $118 | 29,298 (Direct) | View |
| 2019-02-11 Option Award | 2019-02-13 4:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,472 | $0 | 125,553 (Direct) | View |
| 2019-02-11 Option Award | 2019-02-13 4:35 pm | N/A 2029-03-02 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 34,181 | $118 | 125,553 (Direct) | View |
| 2019-02-11 Option Award | 2019-02-13 4:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 12,809 | $0 | 138,899 (Direct) | View |
| 2019-02-11 Option Award | 2019-02-13 4:35 pm | N/A 2029-03-02 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 58,596 | $118 | 138,899 (Direct) | View |
| © 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 Fri, 15 Nov 2019 20:39:15 -0600 | SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |